CIBC World Market
ALXN

CIBC World Market’s Alexion Pharmaceuticals ALXN Stock Holding History

CIBC World Market’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,356
Closed -$498K – 1351
2020
Q3 		$498K Sell
4,356
-185
-4% -$20K ﹤0.01% 824
2020
Q2 		$510K Sell
4,541
-4,340
-49% -$461K ﹤0.01% 786
2020
Q1 		$797K Buy
+8,881
New +$872K ﹤0.01% 602
2018
Q3 		– Sell
-6,976
Closed -$866K – 1255
2018
Q2 		$866K Buy
6,976
+1,022
+17% +$119K ﹤0.01% 708
2018
Q1 		$664K Buy
5,954
+3,754
+171% +$449K ﹤0.01% 767
2017
Q4 		$263K Buy
+2,200
New +$268K ﹤0.01% 690

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

CIBC World Market's ALXN Position: Q4 2020 in Review

CIBC World Market sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 4,356 shares — an estimated $498K sold.

CIBC World Market first reported a position in ALXN in Q4 2017 and held it in 6 quarters. The position peaked at $866K in Q2 2018. 827 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

  • CIBC World Market reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • CIBC World Market sold 4,356 Alexion Pharmaceuticals shares in Q4 2020, an estimated $498K.
  • CIBC World Market first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 6 quarters.
  • CIBC World Market's Alexion Pharmaceuticals position peaked at $866K in Q2 2018.
  • 827 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on CIBC World Market's 13F filing for Q4 2020, filed 8 Feb 2021.